Advanced · 12-24 weeks
SS-31 Clinical High-Dose
Clinical trial-equivalent dosing at 40mg daily SC for 12-24 weeks. The dose used in Phase 2/3 mitochondrial myopathy trials. For serious mitochondrial optimization.
- Type
- single
- Source
- evidence-based
- Pattern
- Continuous during course
Compounds
SS-31
SC · Morning or any consistent time
SC · Morning or any consistent time
40 mg
daily
daily
Phases
Ramp-Up
Weeks 1-2
Weeks 1-2
20
Start at 20mg daily, increase to 40mg
Start at 20mg daily, increase to 40mg
Full Clinical Dose
Weeks 3-12
Weeks 3-12
40
40mg daily — clinical trial equivalent
40mg daily — clinical trial equivalent
Notes
Supply: 40mg/day × 84 days = 3,360mg → 56 × 5mg vials for 12-week course. High-commitment protocol. Excellent safety data from multi-year clinical trials.
Source notes
Phase 2/3 clinical trial dosing: 40mg/day SC. PMID: 29549222. Trials ran up to 260 weeks (5 years). FDA Fast Track designation.
For research and educational use only. This content is not medical advice.